Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-12-02 Raines Heather CFO Grant or award · Stock Options (Right to Buy) +4,197,890 4,197,890
2024-02-28 Raines Heather CFO Returned to the company · 8% Unsecured Convertible Promissory Note due 2022 −0 $50,000.00 $0
2024-02-02 Raines Heather CFO Returned to the company · 8% Unsecured Convertible Promissory Note due 2022 −0 $25,000.00 $0
2021-08-16 Raines Heather CFO Grant or award · 8% Unsecured Convertible Promissory Note due 2022 +0 $200,000.00 $0
2021-06-20 Raines Heather CFO Exercise or conversion · 8% Secured Convertible Promissory Notes due 2021 −0 0
2021-06-20 Raines Heather CFO Exercise or conversion · Series D-1 Convertible Preferred Stock +20,289 20,289
2021-06-17 Raines Heather CFO Grant or award · 8% Secured Convertible Promissory Notes due 2021 +0
2020-11-10 Raines Heather CFO Grant or award +50,000 1,213,153
2019-03-25 Raines Heather Chief Financial Officer Grant or award +50,000 1,163,153

Page 1 of 1 · 9 trades